Levofloxacin


( Last Updated : May 2, 2016)
Generic Name:
Levofloxacin
Project Status:
Complete
Therapeutic Area:
Cystic fibrosis with chronic pulmonary Pseudomonas aeruginosa infections
Manufacturer:
Raptor Pharmaceuticals Inc.
Call for patient/clinician input open:
Brand Name:
Quinsair
Project Line:
Reimbursement Review
Project Number:
SR0493-000
Call for patient/clinician input closed:

Details


Submission Type:
Initial
Indications:
Cystic fibrosis with chronic pulmonary Pseudomonas aeruginosa infections
Recommendation Type:
Reimburse with clinical criteria and/or conditions
Final Recommendation: